The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1

Development ◽  
1994 ◽  
Vol 120 (1) ◽  
pp. 165-175 ◽  
Author(s):  
S. Lawler ◽  
A.F. Candia ◽  
R. Ebner ◽  
L. Shum ◽  
A.R. Lopez ◽  
...  

We have isolated cDNAs of the murine type II TGF-beta receptor and have found a conserved cytoplasmic domain, but a less extensive homology in the extracellular receptor domain between the human and murine homologues. In situ hybridization analysis of the mouse fetus during mid gestation localized the expression of this receptor to various developing tissues, primarily in the mesenchyme and epidermis. This expression pattern correlates well with the expression of TGF-beta in general and especially TGF-beta 1, suggesting that TGF-beta 1 exerts its developmental role through this receptor in an autocrine or paracrine fashion. Type II receptor expression was not detected in the central nervous system and developing cartilage. These tissues lack TGF-beta 1 expression but express TGF-beta 2 and/or TGF-beta 3, suggesting that they may exert their activities through separate receptor isoforms. In addition, the efficient binding of TGF-beta 1, but not TGF-beta 2, to the cloned type II receptor strengthens the likelihood that additional type II receptor isoforms exist which display preferential binding to TGF-beta 2 and have their own defined role in development.

1994 ◽  
Vol 302 (1) ◽  
pp. 199-205 ◽  
Author(s):  
J Lamarre ◽  
J Vasudevan ◽  
S L Gonias

Plasmin regulates the activity and distribution of transforming growth factor beta (TGF-beta) and other growth factors. The purpose of the present investigation was to determine the effects of plasmin on cellular receptors for TGF-beta. AKR-2B fibroblasts were affinity-labelled with 125I-TGF-beta 1 and 125I-TGF-beta 2, demonstrating betaglycan, the type-I TGF-beta receptor and the type-II TGF-beta receptor. Treatment of TGF-beta-affinity-labelled cells with plasmin (10-100 nM) for 1 h profoundly and selectively decreased recovery of TGF-beta-betaglycan complex. The type-I and type-II receptors were not plasmin substrates. A radiolabelled complex with an apparent mass of 60 kDa was detected by SDS/PAGE in both the medium and cell extracts of plasmin-treated affinity-labelled cells. In order to demonstrate that plasmin cleavage of betaglycan did not require prior exposure of the betaglycan to cross-linking agent, AKR-2B cells were treated with plasmin first and then affinity-labelled. Markedly decreased TGF-beta binding to cellular betaglycan was observed. Although plasmin treatment of AKR-2B cells decreased overall binding of 125I-TGF-beta 1 and 125I-TGF-beta 2, the rate at which the cells degraded bound 125I-TGF-beta at 37 degrees C was not changed. AKR-2B cells treated with plasmin demonstrated slightly increased [3H]thymidine incorporation; the plasmin-treated cells retained their ability to respond to TGF-beta. Conditioned medium from plasmin-treated AKR-2B cells contained increased amounts of active TGF-beta as determined in Mv 1 Lu epithelial-cell-proliferation assays. Specific cleavage of betaglycan represents a novel mechanism whereby plasmin may regulate the assortment of receptors available for TGF-beta. In addition, plasmin may facilitate transfer of active TGF-beta between neighbouring cells by releasing the active growth factor from the cell surface.


10.2741/a268 ◽  
1998 ◽  
Vol 3 (4) ◽  
pp. d113-124 ◽  
Author(s):  
Michael Centrella

1993 ◽  
Vol 264 (2) ◽  
pp. F199-F205 ◽  
Author(s):  
U. Haberstroh ◽  
G. Zahner ◽  
M. Disser ◽  
F. Thaiss ◽  
G. Wolf ◽  
...  

Transforming growth factor (TGF)-beta is known to increase mesangial cell (MC) matrix; however, its possible role on MC proliferation is controversial. We therefore studied the influence of TGF-beta on MC proliferation in culture and evaluated its effect on the platelet-derived growth factor (PDGF) B-chain as well as the expression of the PDGF beta-receptor. TGF-beta (1 ng/ml) increases MC DNA synthesis by approximately threefold after 48 h of incubation. TGF-beta-induced MC proliferation was also confirmed by cell counts. A neutralizing anti-TGF-beta antibody completely blocked this growth promoting activity. The levels of PDGF beta-receptor steady-state mRNA were increased by TGF-beta at 48 h. This was associated with an increase in receptor density per cell as measured by receptor kinetic studies. PDGF B-chain mRNA was also increased by TGF-beta at 48 h. A neutralizing anti-PDGF B-antibody causes no reduction of TGF-beta-induced DNA synthesis; however, suramin completely inhibited the mitogenic effect of TGF-beta. We conclude that TGF-beta stimulates MC growth in long-term culture, a process in which upregulation of the PDGF beta-receptor and enhanced synthesis of PDGF B-chain might be involved.


Science ◽  
1993 ◽  
Vol 260 (5112) ◽  
pp. 1344-1348 ◽  
Author(s):  
R Ebner ◽  
R. Chen ◽  
L Shum ◽  
S Lawler ◽  
T. Zioncheck ◽  
...  
Keyword(s):  
Type I ◽  
Type Ii ◽  
Tgf Beta ◽  

Science ◽  
1995 ◽  
Vol 268 (5215) ◽  
pp. 1336-1338 ◽  
Author(s):  
S Markowitz ◽  
J Wang ◽  
L Myeroff ◽  
R Parsons ◽  
L Sun ◽  
...  

2002 ◽  
Vol 36 ◽  
pp. 28
Author(s):  
Toru Nakamura ◽  
Ryuichiro Sakata ◽  
Masaharu Sakamoto ◽  
Takuji Torimura ◽  
Takato Ueno ◽  
...  

Oncotarget ◽  
2016 ◽  
Vol 8 (6) ◽  
pp. 10037-10049 ◽  
Author(s):  
Yong Wu ◽  
Min Su ◽  
ShuX Zhang ◽  
Yu Cheng ◽  
Xiao Y. Liao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document